ARIAD Pharmaceuticals, Inc.
LEI 549300XQ24MXF2Y7K535 · QID Q4653724
Industry: Biological Products, (No Diagnostic Substances)
Time series: Revenue by fiscal year · Net Income by fiscal year
| Fact | Value | Period | Source |
|---|---|---|---|
| entity_legal_form | {"value": "XTIQ", "elf_code": "XTIQ"} | gleif | |
| headquarters_address | {"city": "Cambridge", "region": "US-MA", "street": "26 Landsdowne Street", "country": "US" | gleif | |
| legal_address | {"city": "Wilmington", "region": "US-DE", "street": "C/O The Prentice-Hall Corporation Sys | gleif | |
| legal_jurisdiction | {"value": "US-DE", "scheme": "ISO 3166"} | gleif | |
| legal_name | {"lang": "en", "value": "ARIAD Pharmaceuticals, Inc."} | gleif | |
| observed_web_domain | {"via": "wikidata:P856", "domain": "ariad.com"} | robots_obs | |
| registration_status | {"entity_status": "ACTIVE", "lei_registration_status": "LAPSED"} | gleif | |
| website | {"qid": "Q4653724", "url": "http://www.ariad.com/", "via": "wikidata"} | wikidata |
Cite as: FACTANKER, https://factanker.com/entity/1ee9b9bb-bb16-4b31-a7ef-fa842340655b